Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharm Pract ; 31(1): 82-90, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29278971

ABSTRACT

Human immunodeficiency virus (HIV) has now transformed into a manageable chronic condition. Highly active antiretroviral therapy (HAART) has proven efficacious at controlling the disease progression. Based on compelling evidence, the Department of Health and Human Services (DHHS) and the Infectious Disease Society of America (IDSA) developed guidelines for the management of persons infected with HIV. However, there are approximately 50 000 new cases of HIV in the United States each year. In this article, we review proactive methods to reduce the transmission of HIV, which include reinforcing patient education, gel-coated condoms that destroy HIV, HIV vaccinations, and adequately utilizing pre-exposure prophylaxis (PrEP), and post-exposure prophylaxis (PEP). Further development and consistent utilization of innovative prevention tools can significantly reduce the incidence of HIV infections regardless of HIV status.


Subject(s)
AIDS Vaccines/administration & dosage , Anti-HIV Agents/administration & dosage , HIV Infections/prevention & control , HIV Infections/transmission , Post-Exposure Prophylaxis/methods , Pre-Exposure Prophylaxis/methods , Disease Transmission, Infectious/prevention & control , HIV Infections/epidemiology , Humans , Immunization/methods , Immunization/standards , Post-Exposure Prophylaxis/standards , Pre-Exposure Prophylaxis/standards , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...